WuHan Dong Kang Yuan Technology co., LTD

 

Integrity-based service-oriented Kangyuan products must be boutiques.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsVeterinary Raw Material

Kanamycin Acid Sulphate 25389-94-0 Veterinary Antibacterial Raw Material Powder

Kanamycin Acid Sulphate 25389-94-0 Veterinary Antibacterial Raw Material Powder

Kanamycin Acid Sulphate 25389-94-0 Veterinary Antibacterial Raw Material Powder
Kanamycin Acid Sulphate 25389-94-0 Veterinary Antibacterial Raw Material Powder

Large Image :  Kanamycin Acid Sulphate 25389-94-0 Veterinary Antibacterial Raw Material Powder Get Best Price

Product Details:

Place of Origin: China
Brand Name: DKY
Model Number: 25389-94-0

Payment & Shipping Terms:

Minimum Order Quantity: 1kg
Packaging Details: 1kg/bag or 25kg/drum
Delivery Time: 5-8 work days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 10 tons per year
Detailed Product Description
CAS: 25389-94-0 EINECS: 246-933-9
Molecular Formula: C18H38N4O15S Molecular Weight: 582.58
Melting Point: > 250℃ Specific Rotation: +112~+123°(D/20℃)(c=1,H2O)
Density: 1.3619 Index Of Refraction: 117.5°(C=1,H2O)
Solubility: H2O: 10-50 Mg/mL As A Stock Solution. Stock Solutions Should Be Stored At 2-8℃. Stable At 37℃ For 5 Days. Appearance: Clear Liquid Ranging From Colorless To Yellowish Or Greenish Yellow
High Light:

veterinary pharmaceuticals

,

anti bacterial chemicals

Kanamycin Acid Sulphate 25389-94-0 veterinary raw material antibacterial raw powder
 
Basic parameter:

1. Product name: Kanamycin Monosulfate
2. Product alias: Kanamycin Solution hybri-max; Kanamycin Monosulfate; Kanamycin Sulfate Usp. Kanamycin Sulfate White; Kanamycin Sulfate; Kanamycin Sulfate Salt; Kanamycin Mono Sulphate; Kanamycin Monosulfate Salt; 4, 6 - diamino - 3 - [(6 - amino - - deoxyhexopyranosyl) foxy] - 2 - hydroxycyclohexyl 3 - amino - 3 - deoxyhexopyranoside sulfate (1:1); (1 s, 2 r, 3 r, 4 s, 6 r) - 4, 6 - diamino - 3 - [(6 - amino - - deoxy - alpha - D - glucopyranosyl) foxy] - 2 - hydroxycyclohexyl 3 - amino - 3 - deoxy - alpha - D - glucopyranoside sulfate (1:1); (1 s, 2 r, 4 s, 6 r) - 4, 6 - diamino - 3 - [(6 - amino - - deoxy - alpha - D - glucopyranosyl) foxy] - 2 - hydroxycyclohexyl 3 - amino - 3 - deoxy - alpha - D - glucopyranoside sulfate (salt); 4, 6 - diamino - 3 - [(6 - amino - - deoxyhexopyranosyl) foxy] - 2 - hydroxycyclohexyl 3 - amino - 2, 3 - dideoxyhexopyranoside sulfate (1:1)
3. CAS: 25389-94-0
4. EINECS: 246-933-9
5. Molecular formula: C18H38N4O15S
6. Molecular weight: 582.58
7. Melting point: BBB 0 250
8. Specific rotation: +112 ~ +123°(D/20 ° c)(c=1,H2O)
9. Density: 1.3619
10. Index of refraction: 117.5°(C=1,H2O)
11. Storage conditions: 2-8°C
12. Solubility: H2O: 10-50 mg/mL As a stock solution. Stock solutions should be stored at 2-8℃. Stable at 37℃ for 5 days.
13. Storage conditions: 2-8℃
14. Appearance: clear liquid ranging from colorless to yellowish or greenish yellow
 
Certificate of Analysis:

Product:
Kanamycin Acid Sulphate

C/A No:
  Test Substance Quantity:1KG
Batch No:20200126 Manufacture Date:2020.01.26
Net Weight:25kg/Fiber drum Analysis Date:2020.02.05
As per Standard:USP35 Expiration date:2022.01.25
Items Tested Specification Results

Characters

A white or almost white powder

White Powder

Identification

Meet the regulations Conforms

Acidity or Alkalinity

PH7.0-9.0 8.2

Specific optical rotation

+116°~+123° +119°
solution colour and lustre Yellow, yellowish green ≤3 2
clarity ≤1号 <1号

Kanamycin B

2.0% 0.54%

Sulphate

15.0%~17.0% 15.9%

 
Loss on drying

3.0% 0.6%
On ignition residue ≤0.5% 0.08%
Bacterial endotoxin <0.4EU/1000unit Conforms
Wet product potency(u/mg) —— 762
Dry titer ≥760u/mg 767

Conclusion: Comply with the requirement of standard for USP35

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Structure:
Kanamycin Acid Sulphate 25389-94-0 Veterinary Antibacterial Raw Material Powder 0
 
 

USES:
This product is a broad-spectrum antibiotic of aminoglycoside, the antibacterial spectrum is similar to neomycin. It mainly caused serious infection to gram-negative bacteria such as escherichia coli, klebsiella, proteus, pneumoniae, enterobacter aerogenes and shigella, and also had good antibacterial effect on drug-resistant staphylococcus aureus. Clinically, it is mainly used for pulmonary infection, urinary tract infection, biliary tract sepsis and abdominal cavity infection caused by sensitive bacteria, and the latter two are often combined with other antibiotics. It can also be used in staphylococcus aureus infections that are resistant to other antibiotics and are sensitive to this product. For the treatment of tuberculosis, this product can be used as a second line drug.
 
Principle:
This product is mainly combined with bacterial ribosome 30S subunit to inhibit bacterial protein synthesis. In recent years, the number of drug-resistant strains has increased significantly. Some bacteria produce aminoglycoside passivase, which makes them lose their antibacterial activity. Kanamycin had complete cross-resistance with streptomycin and neomycin, and partial cross-resistance with other aminoglycosides.
This product is mainly combined with bacterial ribosome 30S subunit to inhibit bacterial protein synthesis.
 

Contact Details
WuHan Dong Kang Yuan technology co., LTD

Contact Person: Angela

Tel: 86-15377658509

Send your inquiry directly to us